T. Rowe Price Associates
BHVN icon

T. Rowe Price Associates’s Biohaven BHVN Stock Holding History

T. Rowe Price Associates’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.7M Sell
1,456,851
-760,324
-34% -$8.18M ﹤0.01% 1127
2026
Q1 		$18.8M Buy
2,217,175
+198,625
+10% +$2.17M ﹤0.01% 1060
2025
Q4 		$22.8M Buy
2,018,550
+8,939
+0.4% +$111K ﹤0.01% 1035
2025
Q3 		$30.2M Sell
2,009,611
-1,161,624
-37% -$16.9M ﹤0.01% 951
2025
Q2 		$44.7M Buy
3,171,235
+348,261
+12% +$6.21M 0.01% 759
2025
Q1 		$67.9M Sell
2,822,974
-589,217
-17% -$20.8M 0.01% 629
2024
Q4 		$127M Sell
3,412,191
-26,335
-0.8% -$1.23M 0.01% 522
2024
Q3 		$172M Buy
3,438,526
+154,047
+5% +$5.99M 0.02% 461
2024
Q2 		$114M Sell
3,284,479
-62,543
-2% -$2.47M 0.01% 522
2024
Q1 		$183M Buy
3,347,022
+212,699
+7% +$10.5M 0.02% 435
2023
Q4 		$134M Buy
3,134,323
+791,181
+34% +$24.6M 0.02% 494
2023
Q3 		$60.9M Buy
2,343,142
+165,926
+8% +$3.45M 0.01% 625
2023
Q2 		$52.1M Buy
2,177,216
+532,275
+32% +$9.16M 0.01% 695
2023
Q1 		$22.5M Buy
1,644,941
+328,737
+25% +$5.23M ﹤0.01% 893
2022
Q4 		$18.3M Buy
+1,316,204
New +$18.6M ﹤0.01% 934

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates's BHVN Position: Q2 2026 in Review

T. Rowe Price Associates reduced its Biohaven (BHVN) stake by 34% in Q2 2026, selling an estimated $8.18M and leaving 1,456,851 shares worth $21.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1127.

T. Rowe Price Associates first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $183M in Q1 2024. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • T. Rowe Price Associates held 1,456,851 shares of Biohaven worth $21.7M as of Q2 2026.
  • T. Rowe Price Associates sold 760,324 Biohaven shares in Q2 2026, an estimated $8.18M.
  • Biohaven made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1127 holding.
  • T. Rowe Price Associates first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • T. Rowe Price Associates's Biohaven position peaked at $183M in Q1 2024.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.